XENE

XENE R&D Expense Growth

43.04%Fiscal year

Period ending:

XENE FY R&D Growth (YoY)%
XENE FY R&D Growth (YoY)73.89%-24.54%
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

XENE r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Xenon Pharmaceuticals Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
43.0354%
25.5994%
58.3783%
40.1574%
49.3637%
30.0631%
64.3607%
-7.5822%
28.9742%
30.8606%
28.7559%
-4.3485%
17.6758%
-15.0138%
0%

Compare r&d expense growth

All XENE financial metrics · XENE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.